Paving the Path to Prevention: Managing Early Treatments for T1D Progression
Javier Morales, MD, FACP, FACE; Shira Eytan, MD, FACE; Bethany Kinsey, NP; Quentin Van Meter, MD, and David Robertson, MD, discuss the progression and management of Type 1 diabetes, from early screening protocols through disease stages and intervention timing, emphasizing the critical importance of vigilant monitoring and prompt treatment to prevent severe complications.
EP. 1: Living with Type 1 Diabetes
Panelists discuss how managing Type 1 diabetes requires constant vigilance through blood sugar monitoring, insulin administration, and lifestyle adjustments to maintain healthy glucose levels throughout daily life.
EP. 2: Screening Guidelines for Type 1 Diabetes
Panelists discuss how early screening for Type 1 diabetes involves testing for autoantibodies in at-risk individuals, particularly those with family history or genetic predisposition, to enable prompt intervention and reduce the risk of diabetic ketoacidosis at diagnosis.
EP. 3: Stages and Symptoms of Type 1 Diabetes
Panelists discuss how Type 1 diabetes progresses through distinct stages, beginning with asymptomatic autoantibody presence, followed by abnormal blood sugar levels, and ultimately manifesting with classic symptoms like excessive thirst, frequent urination, and unexplained weight loss.
EP. 4: Impact of Delayed Intervention in Stage 2 Type 1 Diabetes
Panelists discuss discusses how delayed intervention in Stage 2 Type 1 diabetes can accelerate beta cell destruction, leading to more severe clinical onset and increased risk of life-threatening complications like diabetic ketoacidosis.
